Cargando…
Zhibitai and low-dose atorvastatin reduce blood lipids and inflammation in patients with coronary artery disease
BACKGROUND: Atorvastatin decreases blood lipids but is associated with side effects. Zhibitai is a traditional Chinese medicine used to treat blood lipid disorders. The objective of this study is to evaluate the lipid-lowering effect, antiinflammatory effect, and adverse events of zhibitai combined...
Autores principales: | Zhao, Yuhong, Peng, Ran, Zhao, Wang, Liu, Qiong, Guo, Yuan, Zhao, Shuiping, Xu, Danyan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5319516/ https://www.ncbi.nlm.nih.gov/pubmed/28207527 http://dx.doi.org/10.1097/MD.0000000000006104 |
Ejemplares similares
-
Efficacy and safety of Zhibitai in combination with atorvastatin for lipid lowering in patients with coronary heart disease
por: Xu, Danyan, et al.
Publicado: (2017) -
Tranexamic acid reduces perioperative blood loss of posterior lumbar surgery for stenosis or spondylolisthesis: A randomized trial
por: Shi, Houyin, et al.
Publicado: (2017) -
Clinical impact of low-radiation computed tomography coronary angiography diagnosis for coronary artery stenosis: Study Protocol
por: Li, Jian-Jun, et al.
Publicado: (2019) -
Correlation analysis of central arterial pressure parameters and the severity of atherosclerotic lesions in coronary arteries: A retrospective study
por: Fang, Fang, et al.
Publicado: (2023) -
Effects of on-pump versus off-pump coronary artery bypass grafting on myocardial metabolism
por: Xie, Hong-tao, et al.
Publicado: (2019)